Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
CA 2462425 A1 · Owner: Filion, Mario C. · Inventors: Phillips, Nigel C.; Filion, Mario C.; Herrera-Gayol, Andrea Cristina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a composition comprising a 5'-OR 3'- TEG , cholesteryl synthetic sequence wherein the sequence is SEQ ID NO:5 SEQ ID , NO:6, SEQ ID NO:7, SEQ ID NO:8 and a pharmaceutically acceptable carrier. The present invention also provides methods of using of this composition in preparation of medicaments, and methods of using this composition for induction of a response in a cell, including but not limited to inhibition of cellular proliferation, induction of cell cycle arrest induction of caspase , activation, cleavage of poly(ADP-ribose) polymerase induction of apoptosis or , modulation of extracellular matrix-cell interactions or combinations thereof, in cancer …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.